Psychopharmacology
February 1, 2026
Nicole L Zabik, Allesandra Iadipaolo, Craig A Peters et al.
Prior work from our lab and others demonstrates that the endocannabinoid system is a promising avenue for improving fear memory deficits in posttraumatic stress disorder (PTSD). Specifically, 7.5 mg of delta-9-tetrahydrocannabinol (THC) decreases fear responding in healthy adults and increases prefrontal cortex activation during extinction learning and fear renewal in adults with PTSD. The...
Annals of Medicine and Surgery
January 21, 2026
Tirath Patel, Ashfaq Ahmad, Kinza Irshad et al.
Background: Lucid dreaming (LD), which involves being aware of and controlling one’s dreams, is of particular interest in the study of consciousness and has potential therapeutic applications. In this narrative review, we highlight the neurobiological aspects of LD, specifically its mechanisms associated with the activation of prefrontal and parietal areas, increased gamma oscillations, and the...
Frontiers in Network Physiology
2026
Viktor S Matsyshyn, Anatolii M Kravchenko, Nataliia M Ovodiuk et al.
Combat-related stress is associated with autonomic nervous system (ANS) dysregulation-sympathetic predominance, reduced vagal tone, and decreased heart rate variability (HRV)-linked to increased cardiovascular risk. Non-pharmacological interventions targeting autonomic regulation show promise, but controlled studies in combat-exposed populations remain limited. We assessed whether adding a...
Frontiers in Psychiatry
2026
Ngo Cheung
Traditional monoaminergic medications often offer limited relief for the physical and cognitive symptoms of post-traumatic stress disorder (PTSD) and complex PTSD. Growing data now point to fast-acting, glutamate-based treatments that boost synaptic plasticity and interrupt fear-conditioned neural circuits. We report four sequential cases of hard-to-treat trauma-spectrum disorders-somatic PTSD,...
Journal of Eating Disorders
December 29, 2025
Michael Harkhoe, Tim Offringa, Eric Vermetten
Patients with eating disorders (EDs), particularly anorexia nervosa (AN), experience a complex psychiatric condition often characterized by extreme food restriction, intense fear of weight gain, elevated levels of emotional dysregulation, body image disturbance, and comorbid trauma. Several of these factors can undermine the therapeutic alliance and reduce engagement with treatment,...
Psychiatry International
December 24, 2025
Valentina Baldini
Traumatic experiences are among the strongest predictors of suicidal thoughts and behaviors, but the mechanisms that account for this association are still debated. Sleep disturbances, particularly insomnia, nightmares, and fragmented sleep, are highly prevalent after trauma and have been shown to predict suicidality independently of depression and other psychiatric comorbidities. This...
Cureus
December 1, 2025
Paweł Liszka, Agata Ogórek, Klaudia M Olejnik-Chlewicka et al.
Classic psychedelics and related substances, such as 3,4-methylenedioxymethamphetamine (MDMA), have again become a focus of interest in psychiatry as potential therapeutic tools. The aim of this paper is to review current data on their mechanisms of action, clinical applications in the treatment of mood and anxiety disorders, addictions and post-traumatic stress disorder (PTSD), as well as to...
Progress in Neuro-Psychopharmacology and Biological Psychiatry
July 25, 2025
Kiana Askariyan, Mohammad Taghi Joghataei, Samaneh Dehghan et al.
9 citations
The resurgence of psychedelic-assisted psychotherapy marks a pivotal evolution in mental health treatment, challenging traditional paradigms by integrating compounds such as psilocybin, LSD, MDMA, and ketamine into clinical practice. Historically marginalized due to regulatory and societal concerns, these agents are now gaining recognition for their unique neurobiological mechanisms and...
Biological Psychiatry Global Open Science
July 1, 2025
Benjamin Brake, Lillian Wieder, Natasha Hughes et al.
5 citations
Dissociative states, characterized by discontinuities in awareness and perception, occur in a diverse array of psychiatric disorders and contexts. These states have been experimentally modeled in the laboratory through various induction methods, but relatively little is known about the efficacy and comparability of different experimental methods. In this meta-analysis, we quantified...
Psychopharmacology
June 1, 2025
Carmen Abate, Richard Young, Małgorzata Dukat et al.
2 citations
Rationale α-ET (α-ethyltryptamine), a homolog of the classical hallucinogen α-methyltryptamine, was once prescribed clinically as an antidepressant. Classical psychedelic drugs are currently of interest as potential pharmacotherapy for psychiatric disorders. Objectives Drug discrimination was used to (a) determine if α-ET-like stimulus effects could be engendered by the prototypical...